Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
1/10/2025 | $26.00 | Sector Perform | Scotiabank |
10/17/2024 | $27.00 | Buy | BofA Securities |
10/11/2024 | $23.00 → $27.00 | Neutral → Buy | BofA Securities |
9/16/2024 | $24.00 | Underweight → Equal-Weight | Morgan Stanley |
7/19/2024 | $24.00 | Hold → Buy | Argus |
6/4/2024 | $18.00 → $22.00 | Equal Weight → Overweight | Wells Fargo |
3/25/2024 | $22.00 → $20.00 | Buy → Hold | Truist |
10/6/2023 | $20.00 | Buy | Goldman |
Scotiabank initiated coverage of Kinder Morgan with a rating of Sector Perform and set a new price target of $26.00
BofA Securities resumed coverage of Kinder Morgan with a rating of Buy and set a new price target of $27.00
BofA Securities upgraded Kinder Morgan from Neutral to Buy and set a new price target of $27.00 from $23.00 previously
Earnings per Share (EPS) up 11% and Adjusted EPS up 14% Announces $1.7 billion Trident Intrastate Pipeline Project Kinder Morgan, Inc.'s (NYSE:KMI) board of directors today approved a cash dividend of $0.2875 per share for the fourth quarter ($1.15 annualized), payable on February 18, 2025, to stockholders of record as of the close of business on February 3, 2025. This dividend is a 2% increase over the fourth quarter of 2023. KMI is reporting: Fourth quarter earnings per share (EPS) of $0.30, up 11% compared to the fourth quarter of 2023 and Adjusted EPS of $0.32, up 14% compared to the fourth quarter of 2023. Net income attributable to KMI of $667 million, compared to $594 mil
Kinder Morgan, Inc. (NYSE:KMI) today announced it will release fourth quarter 2024 earnings results on Wednesday, January 22, 2025, after market close and will hold a live webcast and conference call. What: Kinder Morgan Fourth Quarter ‘24 Earnings Results Webcast When: January 22, 2025, at 3:30 p.m. CT, 4:30 p.m. ET Where: http://ir.kindermorgan.com/presentations-webcasts How: Live over the Internet by logging on to the web at the above address, or by phone (listen-only) by dialing 1-517-308-9159 and entering the passcode 2172007. If you are unable to listen during the live webcast, the call will be archived at www.kindermorgan.com. A recording of the conference call will also be
Leading U.S. energy company to bring key expertise, best practices, and development of new capabilities to accelerate market growth. QUEBEC CITY and HOUSTON, Jan. 14, 2025 /PRNewswire/ - Flyscan Systems announced today that Kinder Morgan Inc. (NYSE: KMI) is joining its strategic investors Marathon Petroleum (NYSE:MPC), Enbridge (TSX:ENB) (NYSE:ENB) and Hatch to support the company's continued advancement and growth. The funding will enable Flyscan to accelerate commercialization and scale-up of its operations, including its entry in the Natural Gas detection and quantification market.
4 - KINDER MORGAN, INC. (0001506307) (Issuer)
4 - KINDER MORGAN, INC. (0001506307) (Issuer)
4 - KINDER MORGAN, INC. (0001506307) (Issuer)
4 - KINDER MORGAN, INC. (0001506307) (Issuer)
4 - KINDER MORGAN, INC. (0001506307) (Issuer)
Earnings per Share (EPS) up 11% and Adjusted EPS up 14% Announces $1.7 billion Trident Intrastate Pipeline Project Kinder Morgan, Inc.'s (NYSE:KMI) board of directors today approved a cash dividend of $0.2875 per share for the fourth quarter ($1.15 annualized), payable on February 18, 2025, to stockholders of record as of the close of business on February 3, 2025. This dividend is a 2% increase over the fourth quarter of 2023. KMI is reporting: Fourth quarter earnings per share (EPS) of $0.30, up 11% compared to the fourth quarter of 2023 and Adjusted EPS of $0.32, up 14% compared to the fourth quarter of 2023. Net income attributable to KMI of $667 million, compared to $594 mil
Kinder Morgan, Inc. (NYSE:KMI) today announced it will release fourth quarter 2024 earnings results on Wednesday, January 22, 2025, after market close and will hold a live webcast and conference call. What: Kinder Morgan Fourth Quarter ‘24 Earnings Results Webcast When: January 22, 2025, at 3:30 p.m. CT, 4:30 p.m. ET Where: http://ir.kindermorgan.com/presentations-webcasts How: Live over the Internet by logging on to the web at the above address, or by phone (listen-only) by dialing 1-517-308-9159 and entering the passcode 2172007. If you are unable to listen during the live webcast, the call will be archived at www.kindermorgan.com. A recording of the conference call will also be
Phillips 66 (NYSE:PSX) announced today that it has entered into a definitive agreement to sell DCP GCX Pipeline LLC, which owns a 25% non-operated equity interest in Gulf Coast Express Pipeline LLC, to an affiliate of ArcLight Capital Partners, LLC for pre-tax total cash proceeds of $865 million, subject to purchase price adjustments. "With this transaction, we have exceeded our $3 billion asset divestiture target established in our strategic priorities. We intend to continue to optimize the portfolio and rationalize non-core assets going forward," said Mark Lashier, chairman and CEO of Phillips 66. "The evolution of our portfolio underscores our position as a leading integrated downstrea
SC 13G/A - KINDER MORGAN, INC. (0001506307) (Subject)
SC 13G/A - KINDER MORGAN, INC. (0001506307) (Subject)
SC 13G/A - KINDER MORGAN, INC. (0001506307) (Subject)
8-K - KINDER MORGAN, INC. (0001506307) (Filer)
8-K - KINDER MORGAN, INC. (0001506307) (Filer)
144/A - KINDER MORGAN, INC. (0001506307) (Subject)
CAMBRIDGE, Mass., Feb. 22, 2021 /PRNewswire/ -- TriNetX, the global health research network that revolutionizes clinical research and enables discoveries through the generation of real-world evidence (RWE), today announced the appointment of four new members to the company's board of directors including the appointment of former Pfizer CEO and Chairman Ian Read as the company's new Chairman of the Board. The changes to the TriNetX board follows the acquisition of a majority stake in the company by The Carlyle Group in October. In addition to Mr. Read, the new members of the TriNetX board are Steve Wise, Joe Bress, and Ashley Evans from Carlyle. They join current board members Gadi Lachman, J